Publication:
Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosis

dc.contributor.authorEman Bahranien_US
dc.contributor.authorPanitta Sitthinamsuwanen_US
dc.contributor.authorTimothy H. McCalmonten_US
dc.contributor.authorLaura B. Pincusen_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T10:30:47Z
dc.date.available2020-01-27T10:30:47Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 American Society for Clinical Pathology. All rights reserved. Objectives: We observed keratoses with "clonal" nests present as numerous tiny collections, in which cells in "pagetoid" array are found, a configuration we termed microclonal seborrheic keratosis (MSK). To better distinguish MSK from pagetoid Bowen disease (PBD), we investigated use of immunohistochemical staining. Methods: Biopsy specimens of 26 MSKs, 17 PBDs, and 11 borderline cases were reviewed for histopathology and stained with p53, Ki-67, and p16. Results: High expression of Ki-67 and p16 was observed in 12 (80%) of 15 PBDs and in one (4%) of 23 MSKs. Low expression of p16 and high expression of Ki-67 were observed in 16 (70%) of 23 MSKs and in two (13%) of 15 PBDs. Expression of p16 was elevated in 12 (80%) of 15 PBDs and in three (13%) of 23 MSKs (P <. 0001). Conclusions: We describe a "microclonal" variant of seborrheic keratosis with morphology sometimes challenging to distinguish from PBD. High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK.en_US
dc.identifier.citationAmerican Journal of Clinical Pathology. Vol.151, No.6 (2019), 551-560en_US
dc.identifier.doi10.1093/ajcp/aqz001en_US
dc.identifier.issn19437722en_US
dc.identifier.issn00029173en_US
dc.identifier.other2-s2.0-85065669458en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/52264
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065669458&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleKi-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease from "microclonal" Seborrheic Keratosisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065669458&origin=inwarden_US

Files

Collections